Mesoblast Statistics
Total Valuation
Mesoblast has a market cap or net worth of $554.67 million. The enterprise value is $599.11 million.
Market Cap | 554.67M |
Enterprise Value | 599.11M |
Important Dates
The next estimated earnings date is Thursday, May 23, 2024, after market close.
Earnings Date | May 23, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Mesoblast has 108.55 million shares outstanding.
Shares Outstanding | 108.55M |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.75% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 833.33 |
PS Ratio | 76.47 |
Forward PS | 14.76 |
PB Ratio | 1.09 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 82.60 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.24.
Current Ratio | 2.72 |
Quick Ratio | 2.60 |
Debt / Equity | 0.24 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.71 |
Financial Efficiency
Return on equity (ROE) is -14.50% and return on invested capital (ROIC) is -9.33%.
Return on Equity (ROE) | -14.50% |
Return on Assets (ROA) | -10.90% |
Return on Capital (ROIC) | -9.33% |
Revenue Per Employee | $87,386 |
Profits Per Employee | -$880,217 |
Employee Count | 83 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | -188,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.41% in the last 52 weeks. The beta is 2.59, so Mesoblast's price volatility has been higher than the market average.
Beta (1Y) | 2.59 |
52-Week Price Change | -24.41% |
50-Day Moving Average | 3.25 |
200-Day Moving Average | 3.30 |
Relative Strength Index (RSI) | 57.56 |
Average Volume (30 Days) | 2,270,874 |
Short Selling Information
Short Interest | 2.34M |
Short Previous Month | 806,456 |
Short % of Shares Out | 1.14% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.48 |
Income Statement
In the last 12 months, Mesoblast had revenue of $7.25 million and -$73.06 million in losses. Loss per share was -$0.91.
Revenue | 7.25M |
Gross Profit | 7.25M |
Operating Income | -58.88M |
Pretax Income | -73.25M |
Net Income | -73.06M |
EBITDA | n/a |
EBIT | -53.49M |
Loss Per Share | -$0.91 |
Balance Sheet
The company has $77.55 million in cash and $122.00 million in debt, giving a net cash position of -$44.45 million or -$0.41 per share.
Cash & Cash Equivalents | 77.55M |
Total Debt | 122.00M |
Net Cash | -44.45M |
Net Cash Per Share | -$0.41 |
Equity / Book Value | 508.73M |
Book Value Per Share | 4.69 |
Working Capital | 53.79M |
Cash Flow
In the last 12 months, operating cash flow was -$59.10 million and capital expenditures -$231,000, giving a free cash flow of -$59.33 million.
Operating Cash Flow | -59.10M |
Capital Expenditures | -231,000 |
Free Cash Flow | -59.33M |
FCF Per Share | -$0.73 |
Margins
Gross margin is 100.00%, with operating and profit margins of -811.75% and -1,007.28%.
Gross Margin | 100.00% |
Operating Margin | -811.75% |
Pretax Margin | -1,009.87% |
Profit Margin | -1,007.28% |
EBITDA Margin | n/a |
EBIT Margin | -737.49% |
FCF Margin | -818.02% |
Dividends & Yields
Mesoblast does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -25.17% |
Shareholder Yield | -25.17% |
Earnings Yield | -13.17% |
FCF Yield | -10.70% |
Analyst Forecast
The average price target for Mesoblast is $27.33, which is 434.83% higher than the current price. The consensus rating is "Hold".
Price Target | $27.33 |
Price Target Difference | 434.83% |
Analyst Consensus | Hold |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 157.40% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 10, 2024. It was a reverse split with a ratio of 1:2.
Last Split Date | Jan 10, 2024 |
Split Type | Reverse |
Split Ratio | 1:2 |
Scores
Mesoblast has an Altman Z-Score of 0.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.12 |
Piotroski F-Score | 2 |